The global Oral Thin Films Market is estimated to be valued at US$ 2895.55 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Oral thin films are drug delivery systems in a thin, polymeric film configuration for both local and systemic delivery of therapeutics. They provide advantages such as ease of administration, accurate dosing, flexibility in design, and rapid disintegration. Oral thin films undergo instant dissolution in the oral cavity without water requirement and deliver drugs to the bloodstream from underneath the tongue.
Market key trends:
Rise in E-commerce: The growing popularity of e-commerce platforms is boosting the sales of oral thin films. Major companies such as ZIM Laboratories Limited are focusing on selling their oral thin film products online in addition to the availability through pharmacies and drugstores. The availability of convenience and subscription options coupled with rising internet and smartphone penetration globally is propelling the growth of e-commerce channels for oral thin films. This trend is expected to continue over the forecast period.
Segment Analysis
Oral thin films market can be segmented into drug class and distribution channel. Based on drug class, the market is bifurcated into anti-nausea, analgesics, anti-histamines and anti-obesity drugs. Anti-nausea segment dominates the market as oral thin films are effective in treating nausea and vomiting issues. Oral thin films provide quick absorption as compared to tablets, gels and capsules providing fast relief from nausea and vomiting.
Key Takeaways
Global Oral Thin Films Market Demand is expected to witness high growth, exhibiting CAGR of 8.7% over the forecast period, due to increasing preference for convenient dosage forms.
Regional analysis
North America dominates the oral thin films market owing to the growing preference for convenient dosage forms among the population in the US and Canada. Asia Pacific is expected to grow at the fastest rate due to increasing demand for drug delivery through oral thin films in developing nations like India and China.
Key players
Key players operating in the Oral Thin Films market are C L Pharm, Cure Pharmaceutical, Sunovion Pharmaceuticals Inc., ZIM Laboratories Limited, NAL Pharma, Viatris, LTS Lohmann Therapie-Systeme AG, IntelGenx Corp., and Aquestive Therapeutics Inc., among others. C L Pharm provides a wide range of oral thin films including anti-nausea, anti-allergy films under the brand name OraSolv.
Read More- https://www.newsstatix.com/oral-thin-films-market-forecast-analysis-and-outlook/
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the oral thin films market include Pfizer, Inc., ZIM Laboratories Limited, Novartis AG, Wolters Kluwer, Solvay, Allergan plc, Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., Indivior plc and MonoSol Rx.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Oral Thin Films Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/oral-thin-films-market/download-sampleMarket DynamicsThe oral film is made up of hydrophilic polymers that quickly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
Therefore, the sublingual oral thin film is a better alternative for tablets, as it provides complete drug delivery for quick relief.
Therefore, oral thin film medication is developed for swift oral administration of medicines.
The use of oral thin films for preventing gastrointestinal degradation of acid-sensitive drugs will drive the global market.
